<div dir="ltr"><div><p>Dear colleagues,</p><p>Apologies for the cross-posting.<br>
We are pleased to invite you to submit your research contributions
to SBiND 2027, the ICASSP 2027 Satellite Workshop on Speech
Biomarkers for Neurodegenerative Diseases: Signal Processing,
Artificial Intelligence, and Clinical Translation.</p>
<p>SBiND 2027 will take place on May 17, 2027, in Toronto, Canada,
in conjunction with the 2027 IEEE International Conference on
Acoustics, Speech, and Signal Processing (ICASSP 2027).</p>
<p>We warmly welcome contributions from researchers, clinicians,
engineers, and practitioners working at the intersection of speech
and signal processing, artificial intelligence, neurology,
clinical neuroscience, biomedical engineering, and digital health.</p>
<p>We look forward to welcoming you to Toronto!</p>
<p>Kind regards,<br>
The SBiND 2027 Organizing Committee<br>
<br>
===============================================================<br>
SBiND 2027<br>
Speech Biomarkers for Neurodegenerative Diseases: Signal
Processing, Artificial Intelligence, and Clinical Translation<br>
May 17, 2027 \u2013 Toronto, Canada<br>
<a href="https://www.sbind.icar.cnr.it/" target="_blank">https://www.sbind.icar.cnr.it/</a><br>
<br>
Satellite Workshop of the 2027 IEEE International Conference on
Acoustics, Speech, and Signal Processing \u2013 ICASSP 2027<br>
<br>
Submit your paper: <a href="https://cmsworkshops.com/ICASSP2027/papers/submission.asp?ID=7&Type=WS" target="_blank">https://cmsworkshops.com/ICASSP2027/papers/submission.asp?ID=7&Type=WS</a><br>
===============================================================<br>
<br>
MISSION:<br>
Neurodegenerative diseases such as Amyotrophic Lateral Sclerosis,
Parkinson\u2019s disease, and Alzheimer\u2019s disease progressively affect
speech production through changes in motor control, cognition,
language, and respiratory function. Speech and voice therefore
represent promising non-invasive and easily accessible biomarkers
for supporting disease assessment, monitoring progression, and
evaluating treatment response.<br>
SBiND 2027 aims to bring together researchers, clinicians,
engineers, and industry professionals working on speech and voice
biomarkers for neurodegenerative diseases. The workshop will
promote interdisciplinary discussion on the development of
reliable signal-processing and artificial-intelligence methods and
their translation into clinically meaningful and deployable
solutions.<br>
Building on previous research and challenge-based initiatives in
this field, SBiND will address the methodological, clinical, and
technological barriers that currently limit the generalizability,
interpretability, reproducibility, and real-world adoption of
speech-based biomarkers.<br>
<br>
TOPICS:<br>
Topics of interest include, but are not limited to:<br>
\u2022 Speech and voice biomarkers for neurodegenerative diseases<br>
\u2022 Speech signal processing for neurological assessment and
monitoring<br>
\u2022 Acoustic, phonetic, prosodic, linguistic, and conversational
biomarkers<br>
\u2022 Artificial intelligence and machine learning for speech-based
assessment<br>
\u2022 Deep learning, self-supervised learning, and foundation models<br>
\u2022 Automatic detection, classification, and differential diagnosis<br>
\u2022 Longitudinal modelling and disease-progression prediction<br>
\u2022 Multilingual, cross-lingual, and cross-corpus generalization<br>
\u2022 Domain adaptation and robust learning across recording
conditions<br>
\u2022 Explainable and clinically interpretable artificial intelligence<br>
\u2022 Multimodal integration of speech, language, clinical, imaging,
and sensor data<br>
\u2022 Digital phenotyping and remote patient monitoring<br>
\u2022 Mobile, wearable, and telemedicine solutions for speech
assessment<br>
\u2022 Data quality, annotation protocols, and dataset harmonization<br>
\u2022 Privacy-preserving learning and secure health-data processing<br>
\u2022 Federated learning for distributed clinical data<br>
\u2022 Bias, fairness, ethics, and responsible AI in clinical
applications<br>
\u2022 Reproducibility, benchmarking, and open science<br>
\u2022 Clinical validation and real-world deployment<br>
\u2022 Human-centred technologies and clinician\u2013AI collaboration<br>
\u2022 Regulatory and translational challenges for speech-based digital
biomarkers<br>
<br>
IMPORTANT DATES:<br>
\u2022 Paper submission deadline: November 11, 2026<br>
\u2022 Notification of paper acceptance: December 16, 2026<br>
\u2022 Camera-ready paper submission: January 6, 2027<br>
\u2022 Workshop date: May 17, 2027<br>
<br>
PAPER SUBMISSION:<br>
Authors are invited to submit original research contributions
addressing the workshop topics.<br>
Submitted papers must follow the ICASSP 2027 paper style,
formatting, and length requirements. Papers may contain a maximum
of four pages of technical content, including figures and
references, with an optional fifth page containing references
only.<br>
Papers must be submitted through the official ICASSP 2027
Satellite Workshop submission system:<br>
<a href="https://cmsworkshops.com/ICASSP2027/papers/submission.asp?ID=7&Type=WS" target="_blank">https://cmsworkshops.com/ICASSP2027/papers/submission.asp?ID=7&Type=WS</a><br>
All submissions will undergo a rigorous peer-review process
managed independently by the SBiND 2027 Technical Program
Committee.<br>
Accepted and presented papers will be published in the IEEE Xplore
Digital Library under a separate ICASSP 2027 Satellite Workshop
record number.<br>
At least one author of each accepted paper must register for the
workshop and present the paper in person. Papers that are not
presented in accordance with the conference policies will be
withdrawn from the official proceedings.<br>
<br>
BEST PAPER AWARD:<br>
A Best Paper Award certificate will be presented to the author or
authors of an outstanding paper presented at SBiND 2027. The
winning contribution will be selected by the Workshop Chairs based
on scientific significance, originality, methodological quality,
clinical relevance, and the evaluations of the Technical Program
Committee.<br>
<br>
CONTACT:<br>
For further information, please visit: <a href="https://www.sbind.icar.cnr.it/" target="_blank">https://www.sbind.icar.cnr.it/</a><br>
For questions, please contact: <a href="mailto:sbind@icar.cnr.it" target="_blank">sbind@icar.cnr.it</a></p><font color="#888888"></font><br clear="all"></div><br><span class="gmail_signature_prefix">-- </span><br><div dir="ltr" class="gmail_signature" data-smartmail="gmail_signature"><div dir="ltr"><font color="#666666">Nadia Brancati
</font><br><font color="#666666">Senior Researcher @ <a href="https://www.icar.cnr.it/en/gruppi-di-ricerca/artificial-intelligence-in-image-and-signal-analysis/" target="_blank">AI-ISA Lab</a></font><br><font color="#666666">Institute for High Performance Computing and Networking - National Research Council of Italy (CNR - ICAR)</font><br><font color="#666666">Via P. Castellino, 111 - 80131 Napoli
</font><br><font color="#666666">Tel. 081.6139228
</font><br><a href="mailto:nadia.brancati@icar.cnr.it" style="color:rgb(102,102,102)" target="_blank">nadia.brancati@icar.cnr.it</a><font color="#666666"> </font><br></div></div></div>